hydralazine has been researched along with lu 135252 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hergenröder, S; Kirchengast, M; Münter, K | 1 |
| Ehmke, H; Faulhaber, J; Moser, L; Wiesner, RJ | 1 |
2 other study(ies) available for hydralazine and lu 135252
| Article | Year |
|---|---|
Endothelin-A receptor antagonist combined with hydralazine improves survival and renal function in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Endothelin Receptor Antagonists; Hydralazine; Hypercholesterolemia; Hypertension; Kidney; Kidney Function Tests; Male; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Survival | 1998 |
Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Aortic Valve Stenosis; Atrial Natriuretic Factor; Endothelin Receptor Antagonists; Endothelins; Female; Gene Expression; Hydralazine; Hypertrophy, Left Ventricular; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A | 2002 |